An Interesting New Entrant
India’s small-cap market offers considerable long-term opportunities, but identifying businesses capable of delivering sustainable growth is far from easy. Attractive growth stories can conceal weak balance sheets, questionable accounting practices and expensive valuations.
Carnelian Small Cap Fund presents an interesting proposition, brings together experienced capital-market professionals, a forensic research approach and a disciplined investment philosophy.
The fund follows a Quality Growth at a Reasonable Price (QGARP) philosophy, combining business quality, earnings potential and valuation discipline. However, it is a new scheme and has yet to establish its own performance record. The earlier performance of other Carnelian strategies provides useful background, but should not be mistaken for this fund’s track record.
Understanding the Scheme
Carnelian Small Cap Fund is an open-ended equity scheme investing predominantly in small-cap companies, with the objective of generating long-term capital appreciation. Its benchmark is the Nifty Smallcap 250 TRI.
The NFO ran from October 16 to October 30, 2026, specified November 13 for reopening ongoing subscriptions, while exchange notices separately indicated transaction availability from November 9. Investors should verify the current transaction status before investing.
Published expense ratios as of November 9 were 1.01% for Direct Growth and 2.44% for Regular Growth. These figures can change. Investors should check the prevailing TER; the Direct Growth option may suit those who manage their investments independently.
The People Behind Carnelian: Experience Matters
One of the more encouraging aspects of Carnelian is the experience of its founding team. Carnelian was established in 2019 by three professionals:
Vikas Khemani: Founder and Chairman, a Chartered Accountant and CFA charterholder with approximately 27–28 years of capital-market experience. He previously served as CEO of Edelweiss Securities for 17 years.
Manoj Bahety: Co-founder, a Chartered Accountant and CFA charterholder with approximately 28 years of experience. He previously headed research at Edelweiss Securities, with expertise in fundamental and forensic financial analysis.
Swati Khemani: Co-founder, a Chartered Accountant with approximately 24 years of experience. She previously headed the financial services group at Edelweiss Securities.
The scheme is managed by Deepak Malik, CIO and Fund Manager, along with Viraj Parekh, who joined the AMC in March 2026.
Earlier Performance: An Encouraging Track Record
Although Carnelian Small Cap Fund is new, its wider investment-management business has operated since 2019 across PMS, AIF and other investment strategies. According to a July 2026 report, Carnelian managed more than ₹18,300 crore across its investment strategies as of June 2026.
A useful reference is its Capital Compounder Strategy. According to the February 2026 factsheet, the strategy reported the following performance as of January 31, 2026:
Since-inception CAGR: 19.1%, against 15.9% for BSE 500 TRI.
Five-year CAGR: 19.9%, against 16.4% for the benchmark.
Three-year CAGR: 24.9%, against 16.4% for the benchmark.
These figures are encouraging and suggest that Carnelian’s investment-management business has experience in identifying equity opportunities.
However, the returns relate to a multi-cap Capital Compounder Strategy, not Carnelian Small Cap Fund. The figures are reported by Carnelian, calculated net of fees and expenses, and have not been verified by regulatory authorities, according to its factsheet. They provide useful background but cannot guarantee or predict the new scheme’s returns.
Investment Philosophy: Quality Growth at a Reasonable Price
Carnelian follows a QGARP philosophy, combining three important elements:
Quality: Businesses with credible management, sound governance and healthy financial characteristics.
Growth: Companies with opportunities to expand earnings over the long term.
Reasonable valuation: Avoiding excessive prices, even when the underlying business is attractive.
Its approach combines top-down sector research with bottom-up company analysis. Two components deserve particular attention:
Magic Basket: Focuses on businesses experiencing accelerated growth because of structural changes, emerging opportunities or evolving industry trends.
Compounder Basket: Focuses on businesses capable of delivering sustainable earnings growth over longer periods, supported by competitive advantages and efficient capital allocation.
In simple terms, Magic seeks acceleration, while Compounders seek consistency.
Carnelian also emphasises forensic financial research, examining financial statements, cash flows, management quality and corporate governance. This is particularly relevant in small-cap investing, where impressive reported growth does not always translate into sustainable cash generation.
Portfolio Construction: Why the ₹5,000-Crore Cap Matters
Carnelian proposes a concentrated portfolio of approximately 30–50 companies selected from a much wider investment universe. A focused portfolio can provide meaningful exposure to the fund managers’ strongest ideas, although it also increases the impact of individual stock-selection mistakes.
The proposed ₹5,000-crore capacity ceiling is perhaps the scheme’s most interesting feature. Small-cap companies often have limited liquidity. As a fund grows, deploying additional capital and exiting positions during difficult market conditions can become increasingly challenging.
By restricting the fund’s size, Carnelian aims to preserve investment flexibility and avoid excessive asset accumulation.
This is a sensible capacity-management approach. However, a capacity limit is not a guarantee of superior performance or protection against market losses. Its effectiveness will depend on the AMC maintaining the stated discipline.
Investment Outlook: Why the Scheme Deserves Consideration
There are several reasons why Carnelian Small Cap Fund deserves attention. Its founders bring considerable capital-market experience, while the QGARP philosophy combines business quality, earnings growth and valuation discipline. Its forensic research approach places emphasis on financial transparency, cash flows and corporate governance.
Investment Approach: SIP or Lump Sum?
Given small-cap volatility and the absence of an established performance record for this scheme, I would favour a staggered investment approach rather than committing a substantial amount immediately.
An investor considering a ₹5-lakh allocation, for example, could divide the investment into three or four instalments over several months while maintaining a monthly SIP. A SIP spreads investments across different market conditions and reduces the pressure to identify the perfect entry point. It does not eliminate market risk or guarantee returns.
For investors with a five-to-seven-year horizon and the ability to tolerate substantial volatility, a modest initial allocation combined with an SIP appears more sensible. Small-cap exposure should remain a satellite component of a diversified portfolio rather than its foundation.
Key Risks and What Investors Should Monitor
Despite its promising investment philosophy, investors should remain aware of the following risks:
Limited scheme history: The fund has yet to establish its own performance record.
Market volatility: Small-cap stocks can experience substantial corrections.
Liquidity risk: Exiting relatively illiquid holdings can be difficult during market stress.
Valuation risk: Quality businesses can still become expensive investments.
Execution risk: The success of the investment philosophy depends on actual portfolio decisions.
Over the next 12–18 months, investors should monitor portfolio quality, valuation discipline, sector concentration, fund-manager decisions and performance against the Nifty Small Cap 250 TRI.
A new fund should not be judged by a few months of NAV movements. Consistency across different market conditions is far more important.
A Promising Proposition, But Performance Must Follow
Carnelian Small Cap Fund presents an interesting proposition in India’s small-cap mutual fund segment. Its experienced founding team, established investment-management background, QGARP philosophy, forensic research approach and proposed ₹5,000-crore capacity ceiling are meaningful positives.
The Fund deserves a place on the consideration list of investors seeking long-term exposure to small-cap companies. For investors with an appropriate risk appetite and a five-to-seven-year horizon, a modest initial allocation combined with an SIP appears to be a sensible approach.
Avoid an aggressive lump-sum commitment and review the fund after its first 12–18 months, focusing on portfolio quality, valuation discipline and benchmark performance.
The opportunity is interesting, the investment team has a credible background, and the investment philosophy is promising. The real test will be whether these strengths translate into consistent risk-adjusted returns.
A promising philosophy creates expectations. Consistent execution builds investor confidence.
Disclaimer and Disclosure
This report is prepared solely for educational and informational purposes and does not constitute investment advice, a recommendation, an offer or a solicitation to buy or sell mutual fund units or any other securities.
Neither the writer nor Equity Reads has any association or affiliation with Carnelian Mutual Fund, Carnelian Asset Management & Advisors Private Limited, its promoters, founders, fund managers or any of their associated entities. The writer has never met or interacted with the promoters or fund managers and maintains no personal, professional or business relationship with them.
The observations are based on publicly available information, scheme documents and published performance data available at the time of preparation.
Historical performance of other investment strategies does not guarantee or predict the future performance of Carnelian Small Cap Fund.
Small-cap investments carry very high market risk, including volatility, liquidity, valuation and capital-loss risks. Investors should read the Scheme Information Document and Key Information Memorandum carefully and consult a qualified financial adviser before investing.
Equity Reads accepts no responsibility for any investment losses arising from the use of the information or opinions expressed in this report.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully.
Equity Reads | Independent Research. Informed Investing.